1. Synthesis and Structure-Activity Relationships of New Chiral Spiro-β-lactams Highly Active against HIV-1 and Plasmodium. Alves, N.G., I. Bártolo, A.J.S. Alves, D. Fontinha, D. Francisco, S.M.M. Lopes, M.I.L. Soares, C.J.V. Simões, M. Prudêncio, N. Taveira, and E.M.T. Pinho. European Journal of Medicinal Chemistry, 2021. 219: 113439. PMID[33887681].
[PubMed]. HIV_06_2021.
2. Identification of the SHREK Family of Proteins as Broad-spectrum Host Antiviral Factors. Dabbagh, D., S. He, B. Hetrick, L. Chilin, A. Andalibi, and Y. Wu. Viruses, 2021. 13(5): 832. PMID[34064525]. PMCID[PMC8147968].
[PubMed]. HIV_06_2021.
3. INI1/SMARCB1 Rpt1 Domain Mimics TAR RNA in Binding to Integrase to Facilitate HIV-1 Replication. Dixit, U., S. Bhutoria, X. Wu, L. Qiu, M. Spira, S. Mathew, R. Harris, L.J. Adams, S. Cahill, R. Pathak, P. Rajesh Kumar, M. Nguyen, S.A. Acharya, M. Brenowitz, S.C. Almo, X. Zou, A.C. Steven, D. Cowburn, M. Girvin, and G.V. Kalpana. Nature Communications, 2021. 12(1): 2743. PMID[33980829]. PMCID[PMC8115288].
[PubMed]. HIV_06_2021.
4. Design, Synthesis and anti-HIV Evaluation of Novel 5-Substituted diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs. Gao, P., S. Song, Z. Wang, L. Sun, J. Zhang, C. Pannecouque, E. De Clercq, P. Zhan, and X. Liu. Bioorganic & Medicinal Chemistry, 2021. 40: 116195. PMID[33979774].
[PubMed]. HIV_06_2021.
5. Profiles of MicroRNAs in Interleukin-27-Induced HIV-resistant T Cells: Identification of a Novel Antiviral Microrna. Goswami, S., X. Hu, Q. Chen, J. Qiu, J. Yang, D. Poudyal, B.T. Sherman, W. Chang, and T. Imamichi. Journal of Acquired Immune Deficiency Syndromes, 2021. 86(3): p. 378-387. PMID[33196551]. PMCID[PMC7879852].
[PubMed]. HIV_06_2021.
6. Structure-based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity. Huang, B., H. Wang, Y. Zheng, M. Li, G. Kang, V. Barreto-de-Souza, N. Nassehi, P.E. Knapp, D.E. Selley, K.F. Hauser, and Y. Zhang. Journal of Medicinal Chemistry, 2021. 64(11): p. 7702-7723. PMID[34027668].
[PubMed]. HIV_06_2021.
7. Exploring New Scaffolds for the Dual Inhibition of HIV-1 RT Polymerase and Ribonuclease Associated Functions. Meleddu, R., A. Corona, S. Distinto, F. Cottiglia, S. Deplano, L. Sequeira, D. Secci, A. Onali, E. Sanna, F. Esposito, I. Cirone, F. Ortuso, S. Alcaro, E. Tramontano, P. Mátyus, and E. Maccioni. Molecules, 2021. 26(13): 3821. PMID[34201561]. PMCID[PMC8270338].
[PubMed]. HIV_06_2021.
8. Quinolinonyl Non-diketo acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase. Messore, A., A. Corona, V.N. Madia, F. Saccoliti, V. Tudino, A. De Leo, D. Ialongo, L. Scipione, D. De Vita, G. Amendola, E. Novellino, S. Cosconati, M. Métifiot, M.L. Andreola, F. Esposito, N. Grandi, E. Tramontano, R. Costi, and R. Di Santo. Journal of Medicinal Chemistry, 2021. 64(12): p. 8579-8598. PMID[34106711].
[PubMed]. HIV_06_2021.
9. Characterisation of a Highly Potent and near Pan-neutralising anti-HIV Monoclonal Antibody Expressed in Tobacco Plants. Moore, C.M., M. Grandits, C. Grünwald-Gruber, F. Altmann, M. Kotouckova, A.Y. Teh, and J.K. Ma. Retrovirology, 2021. 18(1): 17. PMID[34183026]. PMCID[PMC8240387].
[PubMed]. HIV_06_2021.
10. Anti-VPR Activities of Sesqui- and Diterpenoids from the Roots and Rhizomes of Kaempferia candida. Prema, T. Kodama, H.H.W. Nyunt, H. Ngwe, I. Abe, and H. Morita. Journal of Natural Medicines, 2021. 75(3): p. 489-498. PMID[33687660].
[PubMed]. HIV_06_2021.
11. Selective Cell Death in HIV-1-infected Cells by DDX3 Inhibitors Leads to Depletion of the Inducible Reservoir. Rao, S., C. Lungu, R. Crespo, T.H. Steijaert, A. Gorska, R.J. Palstra, H.A.B. Prins, W. van Ijcken, Y.M. Mueller, J.J.A. van Kampen, A. Verbon, P.D. Katsikis, C.A.B. Boucher, C. Rokx, R.A. Gruters, and T. Mahmoudi. Nature Communications, 2021. 12(1): 2475. PMID[33931637]. PMCID[PMC8087668].
[PubMed]. HIV_06_2021.
12. Synthesis, Enantiomeric Resolution and Biological Evaluation of HIV Capsid Inhibition Activity for Racemic, (S)- and (R)-PF74. Ruddell, S., E. Sugrue, S. Memarzadeh, L.M. Hellam, S.J. Wilson, and D.J. France. Molecules, 2021. 26(13): 3919. PMID[34206893].PMCID[PMC8272108].
[PubMed]. HIV_06_2021.
13. Chemical Space Exploration of Novel Naphthyl-arboxamide-diarylpyrimidine Derivatives with Potent anti-HIV-1 Activity. Sang, Y., C. Pannecouque, E. De Clercq, C. Zhuang, and F. Chen. Bioorganic Chemistry, 2021. 111: 104905. PMID[33895602].
[PubMed]. HIV_06_2021.
14. HIV-1 Protease and Reverse Transcriptase Inhibition by Tiger Milk Mushroom (Lignosus rhinocerus) Sclerotium Extracts: In vitro and in Silico Studies. Sillapachaiyaporn, C. and S. Chuchawankul. Journal ofTraditional andComplementary Medicine, 2020. 10(4): p. 396-404. PMID[32695657]. PMCID[PMC7365780].
[PubMed]. HIV_06_2021.
15. HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants. Smith, S.J., X.Z. Zhao, D.O. Passos, V.E. Pye, P. Cherepanov, D. Lyumkis, T.R. Burke, Jr., and S.H. Hughes. ACS Infectious Diseases, 2021. 7(6): p. 1469-1482. PMID[33686850]. PMCID[PMC8205226].
[PubMed]. HIV_06_2021.
16. Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand Transfer Inhibitor Resistance. Wei, Y. and N. Sluis-Cremer. Antimicrobial Agents and Chemotherapy, 2021. 65(6): e02432-20. PMID[33722887].
[PubMed]. HIV_06_2021.
17. Single-agent and Fixed-dose Combination HIV-1 Protease Inhibitor Drugs in Fission Yeast (Schizosaccharomyces pombe). Zhang, J., K. Vernon, Q. Li, Z. Benko, A. Amoroso, M. Nasr, and R.Y. Zhao. Pathogens, 2021. 10(7): 804. PMID[34202872].
[PubMed]. HIV_06_2021.
Patent Citations
18. Substituted Heterocyclics with Therapeutic Activity in HIV. Debnath, A.K. and F. Curreli. Patent. 2021. 2020-US61239 2021102114: 138pp.
[Patent]. HIV_06_2021.